Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer: ORIGINAL ARTICLE

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 2, 2010, Pages 152-160

  Vinod, S K ^a,b   Kumar, S ^a   Holloway, L C ^a,c,d   Shafiq, J ^a,b  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Dose volume histogram; Non small cell lung cancer; Positron emission tomography; Radiotherapy planning; Tumour control probability

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; DOSIMETRY; HUMAN; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER ASSISTED RADIOTHERAPY; DIAGNOSTIC USE; FEMALE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROCEDURES; PROGNOSIS; RADIATION PROTECTION; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSAGE; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77951271276     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02155.x     Document Type: Article

References (28)

1. Gould MKM, Kuschner WGM, Rydzak CEB et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003 139 : 879 892.
2. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology 1999 213 : 530 536.
3. Vansteenkiste JF, Stroobants SG, De Leyn PR et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998 16 : 2142 2149.
4. Faria SL, Menard S, Devic S et al. Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. Int J Radiat Oncol Biol Phys 2008 70 : 1035 1038.
5. Fitton I, Steenbakkers RJ, Gilhuijs K et al. Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors. Int J Radiat Oncol Biol Phys 2008 70 : 1403 1407.
6. Stroom J, Blaauwgeers H, van Baardwijk A et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys 2007 69 : 267 275.
7. van Baardwijk A, Bosmans G, Boersma L et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007 68 : 771 778.
8. Steenbakkers RJ, Duppen JC, Fitton I et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006 64 : 435 448.
9. De Ruysscher D, Wanders S, Minken A et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 2005 77 : 5 10.
10. Deniaud-Alexandre E, Touboul E, Lerouge D et al. Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers. Int J Radiat Oncol Biol Phys 2005 63 : 1432 1441. (Pubitemid 41628039)
11. MacManus M, D'Costa I, Everitt S et al. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer. Austral Radiol 2007 51 : 386 393.
12. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007 67 : 709 719.
13. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000 55 : 317 324.
14. van Der Wel A, Nijsten S, Hochstenbag M et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 2005 61 : 649 655.
15. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000 12 : 141 144.
16. Morarji K, Fowler A, Vinod S et al. Impact of FDG-PET on lung cancer delineation for radiotherapy (Abstract). J Med Imaging Radiat Oncol 2008 52 (Suppl 2 A105.
17. Nestle U, Kremp S, Schaefer-Schuler A et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005 46 : 1342 1348.
18. Hong R, Halama J, Bova D, Sethi A, Emami B. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys 2007 67 : 720 726.
19. Giraud P, Antoine M, Larrouy A et al. Evaluation of microscopic tumor extension in non-small cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000 48 : 1015 1024.
20. Warkentin B, Stavrev P, Stavreva N, Field C, Fallone BG. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. J App Clin Med Phys 2004 5 : 50 63.
21. SPSS statistical program (Computer program). Version 15. SPSS Inc., Chicago, IL, 2006.
22. Eschmann SM, Bitzer M, Paulsen F et al. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer. Nucl Med Commun 2004 25 : 909 915.
23. Pfannenberg AC, Aschoff P, Brechtel K et al. Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007 34 : 36 44.
24. de Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006 29 : 26 9.
25. De Ruysscher D, Wanders S, van Haren E et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2005 62 : 988 994.
26. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 2009 4 : 5.
27. Klopp AH, Chang JY, Tucker SL et al. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys 2007 69 : 1409 1416.
28. Fox JL, Rengan R, O'Meara W et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 2005 62 : 70 5.